AAS ›› 2015, Vol. 46 ›› Issue (4): 509-513.doi: 10.16098/j.issn.0529-1356.2015.04.011

Previous Articles     Next Articles

Establishment of a tumor-bear mouse model carrying human HepG2 cells and exploration of immune tolerance

LIU Chun-jia ZHANG Xing-yu SHAN Zhi-yan WU Yan-shuang LEI Lei*   

  1. Department of Histology and Embryology, Harbin Medical University, Harbin 150081, China
  • Received:2015-01-13 Revised:2015-06-02 Online:2015-08-06 Published:2015-08-06
  • Contact: LEI Lei E-mail:leiys2002@yahoo.com

Abstract:

Objective To establish anin vivo human hepatoma model carried by mice with normal immune background and to investigate the effect of immune tolerance. Methods We firstly generated green fluorescent protein (GFP) expressed HepG2 cells and intrauterine injected these cells into the peritoneal cavities of E16.5 day mouse fetus. Then we observed the change in newborn mice with bearing cancer and detect the human alpha fetoprotein (AFP) expression in mouse serum by elisa analysis. We subcutaneously injected the HepG2 cells into the adult mice and detected the lymphocyte subgroup ratio of spleen cells by flow cytometry. Results GFP-HepG2 cells were grown in fetus liver and secreted human AFP. After injection of GFP-HepG2 cells in fetus liver, some adult mice developed subcutaneous tumors. Flow cytometry analysis indicated that immune system of tumor-bear mice remained weak attack to human live cancer cells. Conclusion The tumor-bear model carrying human HepG2 cells may be established by injecting the GFP-HepG2 cells into the peritoneal cavities of mouse fetus, parts of which acquire the ability of immune tolerance.

Key words:  Liver cancer, Bearing cancer, Immune tolerance, Flow cytometry, Mouse